Back to search results

Understanding Interest in Integrative Oncology at USC Norris Cancer Center

This study at USC Norris Cancer Center and Keck HC3 Women's Health is looking at what patients think about Integrative Oncology (IO) programs. IO programs offer supportive therapies alongside standard cancer treatments. Researchers want to understand how much patients know about these services, how they feel about them, and if they would be interested in using them. This will help the center decide if and how to offer more IO services. You might be able to join if you are an adult patient at these clinics with a solid tumor or blood cancer, and can speak English, Spanish, or Chinese.

Study design
This is an observational study involving 10 participants. It is not testing a new treatment, but rather gathering information through surveys and focus groups.
What's involved
You would complete a survey and might be asked to participate in a focus group. The study will last up to one year.
Compensation
Not stated in the trial record.
Follow-up
Your knowledge, attitudes, and interest in IO services will be measured throughout the study, for up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07306338

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

Recruiting
Not specifiedAges 18+Observational
University of Southern California
~10 participants
Updated 2026-03-27 on ClinicalTrials.gov
What's tested:Non-Interventional Study

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient knowledge about Integrative Oncology (IO) program services
Measured over Through study completion, up to 1 year
+4 more outcomes measured

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT07306338

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, Californiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Xiaoyue M Guo · PRINCIPAL_INVESTIGATOR · University of Southern California

Who to contact

Xiaoyue M. Guo
[email protected]
323-409-3422
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Ability to understand and the willingness to participate in the study.
English, Spanish, or Chinese speaking
Patient of USC NCCC Outpatient Clinics or Keck HC3 Women's Health outpatient clinic.
Diagnosed solid or hematologic Malignancy

Exclusion

Unable to provide informed consent

What this trial measures

  • Patient knowledge about Integrative Oncology (IO) program servicesThrough study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  • Patient attitudes about IO program servicesThrough study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  • Patient interest in IO program servicesThrough study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.

  • Predictors of willingness to participate or referThrough study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. Adapted survey items from previously published studies (Larbi et al. 2021; Mao et al. 2014), including willingness to participate and pay will be used to asses this outcome.

  • Potential barriers to implementationThrough study completion, up to 1 year

    Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment.